$1.54 7.2%
ASRT Stock Price vs. AI Score (Last 150 days)
Data gathered: July 16

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Assertio Therapeutics

Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system.

Assertio Therapeutics
Price $1.54
Target Price Sign up
Volume 1,660,000
Market Cap $158M
Year Range $0.75 - $2.13
Dividend Yield 0%
Revenue per Employee $4,634,533
Industry Biotechnology

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2432M36M-4.3M-4.5M2M-0.050
Q4 '2332M82M-49M-57M-26M-0.610
Q3 '2335M280M-245M-280M-218M-0.460
Q2 '2340M28M12M8.5M19M0.130
Q1 '2331M29M2.8M-3.5M1.8M-0.070

Insider Transactions View All

Vacirca Jeff L filed to buy 151,159 shares at $1.1.
June 12 '24
Mason Heather L filed to buy 212,650 shares at $1.
June 6 '24
Tyree James L filed to sell 188,251 shares at $1.1.
March 15 '24
Peisert Daniel A. filed to sell 324,939 shares at $3.
September 13 '23
Patel Ajay filed to sell 93,643 shares at $3.
September 13 '23

What is the Market Cap of Assertio Therapeutics?

The Market Cap of Assertio Therapeutics is $158M.

How Many People Work at Assertio Therapeutics?

As of our latest update, Assertio Therapeutics employed approximately 30 people worldwide. However, it's important to note that Assertio Therapeutics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Assertio Therapeutics' revenue per employee?

$4,634,533. To calculate Assertio Therapeutics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Assertio Therapeutics?

Currently, the price of one share of Assertio Therapeutics stock is $1.54.

How can I analyze the ASRT stock price chart for investment decisions?

The ASRT stock price chart above provides a comprehensive visual representation of Assertio Therapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Assertio Therapeutics shares. Our platform offers an up-to-date ASRT stock price chart, along with technical data analysis and alternative data insights.

Does ASRT offer dividends to its shareholders?

As of our latest update, Assertio Therapeutics (ASRT) does not offer dividends to its shareholders. Investors interested in Assertio Therapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Assertio Therapeutics?

Some of the similar stocks of Assertio Therapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.